FDA Inspection 950773 — Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd. on December 4, 2015 in Dongyang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 4, 2015
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dongyang (China)